{"id":13732,"date":"2004-08-18T00:00:00","date_gmt":"2004-08-17T22:00:00","guid":{"rendered":"http:\/\/www.bio-based.eu\/news\/index.php?startid=20040818-04n"},"modified":"2004-08-18T00:00:00","modified_gmt":"2004-08-17T22:00:00","slug":"solanum-glaucophyllum-cure-for-weak-bones","status":"publish","type":"post","link":"https:\/\/renewable-carbon.eu\/news\/solanum-glaucophyllum-cure-for-weak-bones\/","title":{"rendered":"Solanum glaucophyllum &#8211; cure for weak bones"},"content":{"rendered":"<p>Herbonis, based near Basel, already has approval in Switzerland to develop a product for boosting bone growth in animals.<\/p>\n<p>After cardiovascular disease, osteoporosis is the second most prevalent medical problem in the world.<\/p>\n<p><img SRC=\"https:\/\/renewable-carbon.eu\/news\/wp-content\/uploads\/news-images\/20040818-04\/solanum.jpg\" align=\"left\" style=\"margin-right:10px;\" BORDER=\"0\" ALT=\"solanum\"\/>But Herbonis believes it may have found a solution in the plant solanum glaucophyllum or waxyleaf nightshade.<\/p>\n<p>&#8220;It has very favourable properties, as we have already found in animal studies,&#8221; chief executive Beat Glatthaar told swissinfo.<\/p>\n<p><b>Active ingredient<\/b><\/p>\n<p>Herbonis has identified a powerful compound in the waxyleaf nightshade that helps the body to absorb calcium from food, building strong bones.<\/p>\n<p>Inadequate calcium is thought to contribute to the development of osteoporosis.<\/p>\n<p>Worldwide, 30-40 per cent of women suffer a fracture because of osteoporosis. In men, the risk is about 13 per cent.<\/p>\n<p>In several European countries, it is responsible for more hospital stays for women over 45 than any other disease.<\/p>\n<p>Recent studies have forecast that the global market for osteoporosis treatment will triple over the next ten years and be worth about SFr12.5 billion ($9.8 billion) by 2011.<\/p>\n<p>New bone-building agents, which are now becoming available or are in the development pipeline, are expected to capture 29 per cent of the total market.<\/p>\n<p>&#8220;This is exactly the area where Herbonis wants to become active,\u201d said Glatthaar.<\/p>\n<p><b>Calcium deficiency<\/b><\/p>\n<p>Before its product is approved for humans, Herbonis anticipates its use in poultry.<\/p>\n<p>In today\u2019s intensive breeding programmes, chickens are expected to grow to their slaughter weight in five weeks \u2013 compared with seven weeks, 30 years ago.<\/p>\n<p>&#8220;Bone growth just cannot keep pace,&#8221; said Glatthaar. &#8220;A large fraction of these animals suffer from leg weakness and perish.&#8221;<\/p>\n<p>Glatthaar co-founded Herbonis in July 2001 after taking early retirement from Swiss pharmaceutical giant, Roche, where he worked for 24 years in the diagnostic and vitamins division.<\/p>\n<p>The company, which is based in Augst, has five full-time employees.<\/p>\n<p>Partners in the development of solanum glaucophyllum include the University of Applied sciences in Sion and Vitaplant, a Basel University spin-off in Witterswil.<\/p>\n<p>Herbonis refined the extraction process in Sion with federal funding, while Vitaplant, which is active in developing medicinal plants, has helped with the plant-breeding programme.<\/p>\n<p>The company hopes to break even in three years time. In the meantime, it continues to search for investors.<\/p>\n<p>&#8220;When you develop a plant and want to grow substantial amounts of an active substance, it takes time,&#8221; said Glatthaar. &#8220;There\u2019s no way around it.&#8221;<\/p>\n<p>\u00a9 Swissinfo \/ Neue Z\u00fcrcher Zeitung AG<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Herbonis, based near Basel, already has approval in Switzerland to develop a product for boosting bone growth in animals.<\/p>\n<p>After cardiovascular disease, osteoporosis is<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","nova_meta_subtitle":"","footnotes":""},"categories":[5572],"tags":[],"supplier":[],"class_list":["post-13732","post","type-post","status-publish","format-standard","hentry","category-bio-based"],"_links":{"self":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/posts\/13732","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/comments?post=13732"}],"version-history":[{"count":0,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/posts\/13732\/revisions"}],"wp:attachment":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/media?parent=13732"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/categories?post=13732"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/tags?post=13732"},{"taxonomy":"supplier","embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/supplier?post=13732"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}